Internal Medicine, Rheumatology · Glenview, IL
NPI
1942252697
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2401 Ravine Way, Suite 200
Glenview, IL, 60025
Phone (847) 998-5680
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
196,614 services
Medicare patients, 2024
694
Average age 76
Drug cost, 2024
$4.0M
5,069 prescriptions
Company payments, 2025
$80K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfonso Bello was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 80,400 times for 25 patients. In total Alfonso Bello billed 196,614 services in 116 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 80,400 | 25 | $3.59 | $289K |
| J3262 Injection, tocilizumab, 1 mg | Office | 56,170 | 11 | $4.72 | $265K |
| J0897 Injection, denosumab, 1 mg | Office | 22,020 | 222 | $20.42 | $450K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 7,000 | 11 | $33.87 | $237K |
| 99214 Office E&M - Established | Office | 2,163 | 589 | $95.48 | $207K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,800 | 528 | $12.85 | $23K |
| 36415 Venipuncture Blood Collection | Office | 868 | 438 | $8.65 | $7,508 |
| 85025 Blood Count | Office | 801 | 416 | $7.48 | $5,988 |
| 86140 Clinical Chemistry | Office | 772 | 409 | $4.99 | $3,854 |
| 80053 Clinical Chemistry | Office | 768 | 410 | $10.17 | $7,812 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 653 | 129 | $5.34 | $3,486 |
| 96372 Injection Administration | Office | 459 | 221 | $10.00 | $4,588 |
| 96401 Chemotherapy Administration | Office | 356 | 190 | $58.38 | $21K |
| 96365 Intravenous Infusion, Hydration | Office | 289 | 54 | $46.98 | $14K |
| 82306 Clinical Chemistry | Office | 270 | 201 | $28.80 | $7,777 |
By year: 2022 $1.7M for 189,777 services; 2023 $1.8M for 225,418 services; 2024 $2.0M for 196,614 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 868 | 438 | $8.65 | $7,508 |
| 85025 Blood Count | 801 | 416 | $7.48 | $5,988 |
| 86140 Clinical Chemistry | 772 | 409 | $4.99 | $3,854 |
| 80053 Clinical Chemistry | 768 | 410 | $10.17 | $7,812 |
| 82306 Clinical Chemistry | 270 | 201 | $28.80 | $7,777 |
| 86235 Immunoassay | 231 | 33 | $17.57 | $4,059 |
| 86480 Immunoassay | 109 | 103 | $58.51 | $6,378 |
| 84550 Clinical Chemistry | 80 | 53 | $4.38 | $350 |
| 83516 Immunoassay | 78 | 37 | $11.30 | $881 |
| 86200 Immunoassay | 38 | 37 | $12.69 | $482 |
Medicare prescription drug claims, 2024
In 2024, the drug Alfonso Bello prescribed most often to Medicare patients was Prednisone, with 697 prescriptions and refills. In total Alfonso Bello wrote 5,069 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 697 | 1,270 | 199 | $5,265 |
| Hydroxychloroquine Sulfate Generic | 434 | 859 | 136 | $11K |
| Methotrexate Methotrexate Sodium | 392 | 684 | 107 | $9,235 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 313 | 313 | 45 | $10K |
| Gabapentin Generic | 267 | 489 | 89 | $3,981 |
| Meloxicam Generic | 209 | 425 | 80 | $1,129 |
| Leflunomide Generic | 203 | 386 | 78 | $10K |
| Methylprednisolone Generic | 180 | 182 | 131 | $1,156 |
| Allopurinol Generic | 140 | 355 | 48 | $1,830 |
| Sulfasalazine Generic | 136 | 220 | 52 | $2,318 |
| Alendronate Sodium Generic | 135 | 302 | 39 | $1,263 |
| Rinvoq Upadacitinib | 126 | 179 | 20 | $1.1M |
| Tramadol Hcl Generic | 122 | 142 | 30 | $1,224 |
| Oxycodone Hcl Generic | 108 | 108 | 12 | $2,515 |
| Celecoxib Generic | 107 | 218 | 43 | $4,099 |
Brand drugs: - claims; generic drugs: 4,503 claims; opioid claims: 924.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfonso Bello $80K ($80K in general payments such as food, travel and fees) from 20 companies. The largest payer was ANI Pharmaceuticals, Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. ANIP | 45 | $30K |
| Mallinckrodt Hospital Products Inc. | 35 | $15K |
| Amgen Inc. AMGN | 66 | $13K |
| Abbvie Inc. ABBV | 38 | $13K |
| Novartis Pharmaceuticals Corporation NVS | 23 | $7,377 |
| UCB, Inc. UCB.BR | 18 | $395 |
| Pfizer Inc. PFE | 11 | $203 |
| Genzyme Corporation SNY | 9 | $184 |
| Sobi, Inc SOBI.ST | 4 | $183 |
| Lilly USA, LLC LLY | 11 | $176 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.